²é¿´: 2931  |  »Ø¸´: 3

dongningdz

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúһƪ¹ØÓÚ¸ÉÈÅËØµÄ×ÛÊö ÒÑÓÐ2È˲ÎÓë

Çóһƪ¹ØÓÚ¸ÉÈÅËØµÄ×ÛÊöÎÄÕ£¬Ï£ÍûÊÇһƪ·ÖÊý¸ßµÄ£¬¾¡Á¿ÐµÄÎÄÕÂ
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dongningdz

½ð³æ (СÓÐÃûÆø)

2Â¥2014-11-27 21:57:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xuzhu598

Ìú³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
pubmedÀïÃæËÑËѲ»¾ÍÐÐÁË
3Â¥2014-11-28 00:22:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dujianmin

гæ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¦Á»ùÒòÓÕµ¼»úÖÆ²»Í¬ÓÚIFN¦Â»ùÒò,ÓÉ´ËÌá³öÁË
IFN»ùÒòµÄÁ½²½ÓÕµ¼Ä£ÐÍ[9]¡£IFNÉú³ÉµÄÕý·´À¡
µ÷½Ú»úÖÆµÄ´æÔÚ,±£Ö¤ÁËIFNµÄÓÐЧÊÍ·Å¡£IFN
¦Â»ùÒòÊ×ÏÈͨ¹ýIRF3µÄ²¡¶¾ÓÕµ¼»î»¯¶ø±í´ï,
È»ºóIFN¦Á»ùÒò±»ISGF3ÓÕµ¼¡£
3¡¡IFN»ùÒò¹¤³Ì
1980Äê,Derynck¡¢TaniguchiºÍWeissmannµÈ
¿ÆÑ§¼Ò¿Ë¡ÁËÈËIFN»ùÒò;1981ÄêGoeddel±¨µÀ
IFN¦Ã»ùÒò¿Ë¡³É¹¦¡£1982ÄêDeuagerµÈ¸ù¾ÝÈË
IFN°±»ùËá˳Ðò,Ê×ÏÈÓÉÈ˹¤ºÏ³ÉÁËIFN»ùÒò,²¢
¿Ë¡³É¹¦¡£
ÌìÈ»µÄIFN¦Áº¬ÓÐÓÉ21¸ö°±»ùËá²Ð»ù×é³É
µÄÐźÅëÄ,Òò´ËÔڴ󳦸˾úÖй¹½¨±í´ïÐÍÖØ×éÖÊÁ£
ʱ,±ØÐëÈ¥³ýÏàÓ¦µÄÐźÅëıàÂëÐòÁÐ,È»ºó½«³ÉÊì
½á¹¹µ°°×»ùÒòÓë´ó³¦¸Ë¾úµÄijһ»ùÒòÖØ×éÒÔ±í´ï
Èںϵ°°×¡£¦Á1ÐÍIFNÓëIFN¦ÁÓÉÓÚ·Ö×ÓÖк¬ÓÐ
Ò»¸öÓÎÀëµÄ°ëë×°±ËáÛÏ»ù,ÔÚÀûÓô󳦸˾úÖØ×é±í
´ïʱ,ÈÝÒ×ÐγɷÖ×Ó¼ä¶þÁò¼ü½»Áª¶ø²úÉúÏàÓ¦µÄ¹Ñ
¾ÛÌå,½µµÍÆäÉúÎï»îÐÔ¡£³ýÁ˴󳦸˾úÍâ,¸÷ÐÍ
IFN»ùÒòÒÑÔڿݲÝÑ¿æß¸Ë¾ú¡¢Á´Ã¹¾úÒÔ¼°½Íĸ¾úÖÐ
»ñµÃ¸ßЧ±í´ï¡£
1998Äê,Manuel RodriguezºÍVladimir Mar-
tinezµÈ±¨µÀÔÚ±ÏÊϽÍĸÖиßˮƽ±í´ïÅ£IFN¦Ø1
»ùÒò¡£±àÂëbIFN¦Ø1µÄ»ùÒò²ÉÓÃPCR·½·¨´ÓÅ£
ȾɫÌå×éDNAÖзÖÀë,ÖØ×ébIFN¦Ø1ÔÚ±ÏÊϽÍ
ĸÖбí´ï,²¢ÓиßË®Æ½ÖØ×éµ°°×·ÖÃÚµ½ÅàÑø»ùÖС£
»ñµÃµÄbIFN¦Ø1ÔÚ¿¹²¡¶¾»îÐÔ·½Ãæ²»±íÏÖÖÖ×å
ÌØÒìÐÔ¡£bIFN¦Ø1»ùÒòΪ600 bpƬ¶Î,±»¿Ë¡µ½
pPS7±í´ïÔØÌåNcoIλµã,ÐγÉpPBIÔØÌå,ÊܱÏÊÏ
½ÍĸpAOX1ÔöÇ¿×Óµ÷¿Ø¡£bIFN¦Ø1»ùÒòÔÚÅàÑø
»ùÖÐÓÉÕáÌÇת»¯½ÍËØÐźÅëĸßЧÓÕµ¼±í´ï¡£ÒÔǰ,
ÆäËüÒìÔ´µ°°×Ò²±»±ÏÊϽÍĸ¸ßˮƽ±í´ï¹ý,½«ÕâÒ»
·ÖÃÚÐźÅÓ¦ÓÃÓÚpPS7ÔØÌåÖÐ,ÓÐÀûÓÚÒìÔ´µ°°×ÔÚ
±ÏÊϽÍĸÖбí´ï[10]¡£
4¡¡IFNÓë»ùÒòÖÎÁÆ
IFN¾ßÓÐÏÔÖøµÄ¿¹²¡¶¾¡¢ÒÖÖÆÖ×Áöϸ°ûÔöÖ³¼°
ÃâÒßµ÷½ÚµÈÉúÎï»îÐÔ¡£Ö×Áö×÷ΪһÖÖ·Ö×Ó²¡,·¢²¡
»úÖÆÊÇÓÉÓÚ°©»ùÒò¼°ÒÖ°©»ùÒòµÄÍ»±äËùÖÂ,Òò´Ë»ù
ÒòÖÎÁÆÊÇսʤÖ×ÁöµÄÒ»ÖÖÖØÒªÊֶΡ£IFNÓÐÍûÓ¦
ÓÃÓÚÖ×ÁöµÄ»ùÒòÖÎÁÆ¡£½«IFN¦Ã»ùÒò½èÖúÓÚÄæ
ת¼²¡¶¾ÔØÌåµ¼Èëµ½¿¹Ô­ÐÔºÜÈõµÄСÊóÏËάÈâÁö
CMS 5ϸ°ûϵÖÐ,ʹÆä·ÖÃÚ×ã¹»Á¿µÄIFN¦Ã¡£
ʵÑé֤ʵ,ÓÉÓÚIFN¦ÃÄÜʹCMS5ϸ°ûµÄMH-
CIÀ࿹ԭ±í´ïÔöÇ¿,ÓÚÊǾßÓÐת»ùÒòCMS5ϸ°û
µÄСÊó±ã²úÉúÁ˶ÔCMS5ÌØÒì¡¢³Ö¾Ã¡¢ÓÉɱÉËTÁÜ
°Íϸ°û(CTL)½éµ¼µÄ±£»¤ÐÔÃâÒßÓ¦´ð·´Ó¦¡£CTLÄÜ
¶ÔÖ×Áöϸ°û²úÉúÃâÒßÓ¦´ð·´Ó¦,ʶ±ð²¢É±ÉËÖ×Áöϸ
°û¡£
ËäȻϸ°ûÒò×Ó»ùÒò¹¤³Ì²úÆ·ÒÑ¿ªÊ¼Ó¦ÓÃÓÚÁÙ
´²,µ«´æÔÚµÄÒ»¸öÍ»³öÎÊÌâÊÇÕâЩϸ°ûÒò×ÓÔÚÌåÄÚ
µÄ°ëË¥ÆÚ¶¼ºÜ¶Ì,ÈôÒª´ïµ½ÖÎÁÆË®Æ½,±ØÐë³ÖÐø´ó
¼ÁÁ¿×¢Éä,ÓÉ´Ë»á²úÉúһϵÁи±×÷Ó᣻ùÒòÁÆ·¨Ìá
¹©ÁËÒ»ÖÖ½ÏΪÀíÏëµÄ¸øÒ©·½Ê½,ʹѪҺÖÐϸ°ûÒò×Ó
µÄˮƽÎȶ¨µØÎ¬³ÖÔÚÁÆÐ§·¶Î§ÄÚ,ÓÈÆäÔڰв¿Î»±£
³ÖÌØÒìÐÔ¸ßŨ¶È¡£ÓÃÖ¬ÖÊÌå°üÂñº¬ÓÐÈËIFN¦Ã
»ùÒòµÄÕæºË±í´ïÖÊÁ£,²¢ÔÚÆä±íÃæÇ¶ÈëÄÜʶ±ðÈ˽º
ÖÊÁöµÄµ¥¿Ë¡¿¹Ìå,ÕâÖÖÖ¬ÖÊÌå½øÈëÌåÄÚºó,ÌØÒì
ÐÔµØÓ뽺ÖÊÁöϸ°û·¢ÉúÈÚºÏ,Ôڴ˹ý³ÌÖÐͬʱ½«
IFN¦Ã»ùÒòµ¼ÈëÖ×Áöϸ°û,¶¨Î»±í´ïµÄIFN¦Ã
±ãÒÖÖÆÆäÔöÖ³¡£
5¡¡Õ¹Íû
ÔÚ¸ÉÈÅËØÑо¿ÖÐ,»¹ÓÐһЩÀíÂÛÓëʵ¼ù·½ÃæµÄ
ÎÊÌâÐèÒª½øÒ»²½Ì½ÌÖ¡£µÚÒ»,²»Í¬À´Ô´¸ÉÈÅËØ×éÖ¯
Ç׺ÍÐÔÓëÉúÎïѧ×÷ÓÃÓдý½øÒ»²½Á˽⡣¸ÉÈÅËØÖÖ
Àà½Ï¶à,¶øÇÒ¾ßÓжàÖÖÑÇÐÍ,ËüÃǵÄÉúÎïѧ¹¦ÄÜÈÔ
ÐèÒª¸üÉîÈëÁ˽⡣µÚ¶þ,¸ÉÈÅËØµÄ·Ö×ӽṹÐèÒªÉî
ÈëÑо¿,²¢Òª´Ó¶àÖÖ½Ç¶È¶ÔÆä½øÐиÄÔì,´Ó¶ø¸üÓÐ
ЧµØ·¢»ÓÆäÉúÎ﹦ÄÜ,²¢¸³ÓèÐµĹ¦ÄÜ¡£µÚÈý,ÖØ
×é¸ÉÈÅËØ²»ÄÜ´óÁ¿Éú²ú,Éú²ú³É±¾Ì«¸ßÏÞÖÆÁËÆä¹ã
·ºÓ¦Óá£ÎÒÃÇÓ¦¸Ã̽Ë÷¸üÓÐЧµÄ»ùÒò±í´ïÌåϵ,ÒÔ
Äܸßˮƽ±í´ï¸ÉÈÅËØ»ùÒò¡£µÚËÄ,¸ÉÈÅËØµÄÌá´¿ºÍ
²â¶¨·½·¨Éв»¹»Îȶ¨ºÍ¼ò»¯,Ó°ÏìÁ˸ÉÈÅËØµÄ×÷
ÓÃЧ¹û,Õâ·½ÃæÒ²Ðè½øÒ»²½¸Ä½ø¡£
¸ÉÈÅËØ¾ßÓйãÀ«µÄÓ¦ÓÃǰ¾°,ÀûÓûùÒò¹¤³Ì¼¼
ÊõÉú²úÖØ×é¸ÉÈÅËØ²úÆ·¾ßÓкܺõÄÁÙ´²Ð§¹û¡£¸É
ÈÅËØÖÎÁÆÒ»°ãÎÞÑÏÖØ¸±×÷ÓÃ,Ö÷ÒªÓÃÓÚÁÙ´²Ö×Áö¡¢
²¡¶¾ÐÔ¸ÐȾµÈµÄÖÎÁÆ,ÈçÂýÐÔÒҸΡ¢±û¸Î¡¢²¡¶¾ÐÔ½Ç
ĤÑ׵ȡ£ÔÚÐóÄÁÒµÖÐ,¸ÉÈÅËØÓ¦Óù㷺,ÆäÖÆ¼Á¿É
ÓÃÓÚÔ¤·ÀÓëÖÎÁƶàÖÖ¶¯Îï¼²²¡,ÓÈÆäÊǶÔÁ÷¸Ð¡¢ÐÂ
³ÇÒߵȲ¡¶¾¸ÐȾ¾ßÓнϺõķÀÖÎЧ¹û¡£´ËÍâ,¸ÉÈÅ
ËØ¿ÉÒÔ²ÉÓÃÒ©Îï¿ØÊͼ¼ÊõÖÆ×÷³É½ºÄÒ»òÕßÄÉÃ×Á£
×Ó,ÓëÊÊÒËÔØÌå½áºÏ,×÷Ϊ±£½¡ÐÍËÇÁÏÒ©ÎïÌí¼Ó¼Á
ʹÓá£
²Î¿¼ÎÄÏ×
[1]Campbell Lain,LK Thomas.Structural and functional neuropath-
¡¤24¡¤ÖйúÊÞÒ©ÔÓÖ¾¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡2003,37(6):22¡«25/ØÁÁ¢·å,µÈ¡¡
×Ó2¡«4·Ö±ð±àÂë23¡¢60¡¢40¸ö°±»ùËá,ÍâÏÔ×Ó4Ò²
±àÂëÖÕÖ¹×ÓÓë3'UTR,ÍâÏÔ×Ó2Óë4µÄ°±»ùËáÐò
ÁоßÓи߶ȱ£ÊØÐÔ,·Ö±ðΪ56.5%Óë42.5%¡£Èý
¸öÄÚº¬×Ó׼ȷ²åÈëÁ½¸öÃÜÂë×ÓÖ®¼äµÄ¿ª·ÅÔĶÁ¿ò¡£
ÄÚº¬×Ó¶¼¾ßÓб£ÊØÐÔÐòÁÐ,°üÀ¨5'GTÓë3'AG¡£
¾¡¹Ü°±»ùËáÐòÁдæÔÚ²îÒì,µ«IÐÍIFN¾ßÓÐ
ÏàËÆµÄÈýά½á¹¹,¶¼ÓɽôÃÜÅÅÁеĦÁÂÝÐý½á¹¹Óò¹¹
³É,²¢±íÏÖ³öÏàËÆµÄÉúÀí¡¢Éú»¯ÌØÕ÷,Èç¶ÔpHµÄÎÈ
¶¨ÐԺͶÔͬÀàϸ°û±íÃæÊÜÌåµÄʶ±ð¡£IFN¦ÃÊÇÒ»
ͬÐͶþ¾ÛÌå,ÿһ¸öÔ­Ìåϸ°ûÖк¬ÓÐÓëIFN¦ÂÅÅ
ÁÐÏàËÆµÄÂÝÐýÇø,ËüµÄϸ°û±íÃæ½áºÏÊÜÌåÒ²²»Í¬ÓÚ
¢ñÐÍIFN[2]¡£IFN¦Á1ÐÍ·Ö×ÓÖк¬ÓÐ5¸ö°ëë×°±
ËáµÄ²Ð»ù,ÐγÉ2¶Ô¶þÁò¼ü,·Ö±ðΪCys1Cys98
ºÍCys29Cys138,µÚ85λÉϰëë×°±ËáµÄÛÏ»ùÓÎ
Àë¡£¦Á2ÐÍIFNÔÚµÚ85λ²»Êǰëë×°±Ëá,¶øÊÇÀÒ°±
Ëá,ËüËùÐγɵĶþÁò¼üÓë¦Á1ÐÍÍêÈ«Ïàͬ¡£IFN¦Â
·Ö×ÓÖк¬ÓÐ3¸ö°ëë×°±Ëá²Ð»ù,ÆäÖÐÄÜÐγɶþÁò¼ü
µÄÊÇCys31Cys141,ËüÓëIFN¦ÁµÄCys29
Cys138½á¹¹Í¬Ô´,µÚ17λµÄ°ëë×°±ËáÛÏ»ùÓÎÀë¡£
IFN¦Ã²»º¬°ëë×°±Ëá,ÔÚµÚ25λºÍµÚ97λµÄ
Asn´¦ÓÐÁ½¸öNÌÇ»ù»¯Î»µã¡£
2¡¡IFN¼°Æä»ùÒò±í´ï
2.1¡¡IFNÆô¶¯×ÓÓëIFN±í´ïµ÷¿Ø¡¡IFNµÄ±í´ï
ÊܶàÖÖת¼Òò×Ó¡¢Ï¸°ûÒò×Ó¼°µ÷¿ØÔª¼þµÄµ÷½Ú¡£Èç
°×ϸ°û½éËØ¡¢IFNµ÷¿ØÒò×Ó(IRF)¡¢Ï¸°û·ÖÁÑËØµÈ¡£
IFNµÄ±í´ïµ÷¿ØÖ÷ÒªÔÚת¼ˮƽ¡£IFN»ùÒòÆô¶¯
×Ó¡¢ÄÚº¬×Ó¼°3'UTRÖж¼´æÔÚһЩDZÔڵĵ÷¿ØÐò
ÁС£²¸È鶯ÎïÖÐ,Ðí¶àÖØÒªµÄIFNת¼µ÷¿ØÔª¼þ
λÓÚת¼ÆðʼµãµÚÒ»¸ö150 bpÉÏÓÎÇø¡£ÕâЩµ÷¿Ø
Ôª¼þ°üÀ¨TATAATAÓëCCATbox¡£Æô¶¯×ÓÇø
Ò²°üº¬Ò»¸öDZÔÚµÄNFkB¼Ò×å½áºÏλµã¡£Penix
µÈÔÚÈ˵ÄIFN¦Ã»ùÒòÆô¶¯×ÓÖз¢ÏÖÁËÁ½¸ö±ØÐè
µÄµ÷¿ØÔª¼þ,ËüÃÇÒ²´æÔÚÓÚÆäËü²¸È鶯ÎïIFN¦Ã
»ùÒòÆô¶¯×ÓÖС£Ä©¶Ë±£ÊØÔª¼þ°üº¬Ò»¸öÏàͬµÄ·´
ÏòGATAλµãÓëÒ»¸öDZÔڵĵ÷½Úλµã,Ëü´æÔÚÓÚ
º¬ÓÐCCATboxµÄGMCSFÓëMIP»ùÒòµÄÆô
¶¯×ÓÇø[3]¡£
2.2¡¡IFN¼¤»î»ùÒòµÄ±í´ï¡¡IFN´Ù½ø»ùÒò±í´ïÒÔ
·¢»ÓÉúÎï»îÐÔ¡£ÓÉÐźŽéÖʺÍת¼¼¤»îÎï(signal
transducers and activators of transcription,STATs)
STAT1¡¢STAT2¡¢p48×é³ÉµÄ¸´ºÏת¼Òò×ÓÊÇÒ»ÖÖ
DNA½áºÏµ°°×,³ÆÎªIFN¼¤»îµÄ»ùÒòÒò×Ó3(IFN
stimulated gene factor 3,ISGF3),Ëüµ÷¿ØIFN¦Á/
¦Â¼¤»î»ùÒòµÄ±í´ï¡£ÓëIFN¦ÃÏà±È,IFN¦Á/¦ÂÐè
Òª¸ß¼ÁÁ¿ÓÕµ¼p48Æô¶¯×Ó,IFN¦Á/¦Âͨ¹ýIFN¦Á
ÓÕµ¼Òò×ӻµ÷¿ØGATE(IFN¦Ã»î»¯×ªÂ¼Òò×Ó)
ÒÀÀµ»ùÒòµÄ±í´ï,IFN¦ÃÓÕµ¼Á½¸öIFN¦ÃÓÕµ¼
Òò×Ó½áºÏµ½GATEÉÏ,IFN¦ÃÊÇGATEÒÀÀµ»ùÒò
µÄÇ¿ÓÕµ¼Îï[4]¡£
IFNͨ¹ýÓëϸ°ûÒò×ÓÊÜÌå¿çĤµ°°×ϸ°ûÍâÇø
ÓòÏ໥×÷ÓÃ,¼¤·¢°Ðϸ°ûÐźŴ«µ¼¡£ÕâЩÊÜÌå²»ÄÜ
ʶ±ðϸ°ûÖʸÐÊÜÆ÷ÇøÓò,ËüÃÇÌØÒìÐÔµØÓëϸ°ûÖÊ
JAK¼Ò×åµ°°×ÖÊÀÒ°±ËἤøÏ໥×÷Óá£STATÖÐ
µÄÌØÒìÀÒ°±Ëá²Ð»ù±»JAKsÁ×Ëữ¼¤»îºó,ÓëÁ×Ëá
»¯ÀÒ°±ËáµÄSrcÍ¬Ô´Çø2(SH2)Ï໥×÷ÓÃÐγÉͬÌå
ºÍÒìÌå¶þ¾ÛÌå(STAT¶þ¾ÛÌå),½áºÏµ½»ùÒòµÄ¦Ã
¼¤»îÐòÁÐ(gamaactivated sequence,GAS)Éϼ¤»î
»ùÒòµÄ±í´ï¡£²»Í¬µÄGASÓ벻ͬµÄSTAT¶þ¾ÛÌå
½¨Á¢ÌØÒìÐÔ·´Ó¦¡£¸´ºÏת¼Òò×Ó(ISGF3)ͬһ¸ö
½á¹¹ÉÏÓëGASåÄÈ»²»Í¬µÄIFN¼¤»îµÄµ÷½ÚÐòÁÐ
(IFN stimulated regulated elements,ISREs)½áºÏ¡£
ISREs´Ù½ø¶àÊýIFN¦Á/¦Âµ÷¿ØµÄ»ùÒòÓëÉÙÊýIFN
¦Ãµ÷¿ØµÄ»ùÒòµÄ±í´ï¡£º¬ISREsÐòÁеĻùÒòÒ²ÄÜ
±»ISGF3¶ÀÁ¢ÓÕµ¼,´ó²¿·Öͨ¹ýIRF1µÄ×÷
ÓÃ[5]¡£
2.3¡¡×ªÂ¼Òò×ÓÓÕµ¼IFN»ùÒò±í´ï¡¡ÔÚIFNµ÷¿Ø
Òò×Ó¼Ò×åÖÐ,IRF3²ÎÓ벡¶¾ÓÕµ¼IFN¦Â»ùÒòµÄ
±í´ï,ÁíÒ»³ÉÔ±IRF7¶ÔÓÚIFN¦Á»ùÒòÓÕµ¼Æð
ÖØÒª×÷ÓÃ,IRF7²ÎÓ벡¶¾ÓÕµ¼Ï¸°ûºËÄÚתλ,
IRF 7Òì³£±í´ïÄܹ»ÓÕµ¼IFN¦Á»ùÒò±í´ï¡£Õâ
Щ½á¹û±íÃ÷IRF7ÊÇIFN¦Á/¦ÂÕý·´À¡µ÷¿ØÖеÄ
Ö÷ÒªÒò×Ó[6]¡£
IFNµ÷¿ØÒò×Ó3(IRF3)Óëµ÷¿ØÒò×Ó7(IRF
7)ÔڻIÐÍIFN»ùÒò±í´ïÓëÓÕµ¼¿¹²¡¶¾»îÐÔÖÐ
·¢»ÓÖØÒª×÷ÓÃ,ת¼Òò×Ó¾ßÓÐÏàͬµÄ½á¹¹¡¢¹¦ÄÜÌØ
Õ÷¼°¹²Í¬µÄ̼¶ËÁ×Ëữ»î»¯»úÖÆ,IRF3¡¢IRF 7
»î»¯¹ý³ÌÖоßÓÐÏàËÆµÄÐźÅתµ¼Í¾¾¶¡£IRF3¡¢
IRF 7ÄÜÑ¡ÔñÐÔµ÷¿ØIÐÍIFNÓëIFN¼¤»î»ùÒò
(ISG)µÄ±í´ï[7]¡£×ªÂ¼Òò×Ó¼Ò×åÖÐIRF²ÎÓëIFN
ϵͳµ÷¿Ø,IRF1Óëp48¶ÔÓÚIFN½éµ¼¿¹²¡¶¾Ó¦
´ð·Ç³£ÖØÒª,p48ÊÇISGF3µÄ±ØÒª×é³É¡£×î½üÑо¿
±íÃ÷IRF¼Ò×åÖÐÁíÒ»³ÉÔ±IRF3ÔÚ²¡¶¾ÓÕµ¼
IFN¦Â»ùÒò»î»¯ÖÐÆðÖØÒª×÷Óá£ÊÂʵÉÏ,IRF3
´æÔÚÓÚÕý³£Ï¸°ûµÄϸ°ûÖÊÖÐ,ÔÚ¸ÐȾ²¡¶¾Ï¸°ûÖÐ,
Ëü±»Á×Ëữ²¢×ªÎ»µ½Ï¸°ûºËÄÚ,»î»¯µÄIRF3Óë
CBP/p300¹²Í¬´Ù½øIFN¦ÂÆô¶¯×Óת¼[8]¡£IFN
¡¤23¡¤¡¡2003,37(6):22¡«25/ØÁÁ¢·å,µÈ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ÖйúÊÞÒ©ÔÓÖ¾
¸ÉÈÅËØµÄ·Ö×ÓÉúÎïѧÑо¿½øÕ¹
ØÁÁ¢·å,Ðíè÷ÈÙ
(Õã½­´óѧËÇÁÏ¿ÆÑ§Ñо¿Ëù,½ÌÓý²¿¶¯Îï·Ö×ÓÓªÑøÑ§ÖØµãʵÑéÊÒ,Õã½­º¼ÖÝ¡¡310029)
[ÊÕ¸åÈÕÆÚ]2002 12 26¡¡[ÎÄÏ×±êʶÂë]A¡¡[ÎÄÕ±àºÅ]1002 1280(2003)06 0022 04¡¡[ÖÐͼ·ÖÀàºÅ]R979.5
[Õª¡¡Òª]¡¡¸ÉÈÅËØÊÇÒ»Àà¶à¹¦ÄÜϸ°ûÒò×Ó,ÊÇÓɲ¸È鶯ÎïÌåϸ°ûºÏ³ÉÓë·ÖÃÚµÄDZÔÚµÄÉúÎï»îÐÔ
µ°°×ÖÊ,¾ßÓеֿ¹²¡¶¾¸ÐȾ¡¢ÒÖÖÆÖ×Áöϸ°ûÉú³¤Óëµ÷½Ú»úÌåÃâÒß¹¦ÄܵÄ×÷ÓÃ,Æä»ùÒò±í´ïÊܶàÖÖ
ÒòËØºÍµ÷¿ØÔª¼þµÄµ÷½Ú¡£¸ÉÈÅËØ»ùÒò¹¤³ÌºÍ»ùÒòÖÎÁÆÑо¿ÒýÆðÁ˹㷺µÄ¹Ø×¢,ĿǰÒѱ»Ó¦ÓÃÓÚ
ÁÙ´²ÖÎÁÆ¡£
[¹Ø¼ü´Ê]¡¡¸ÉÈÅËØ(IFN);»ùÒò±í´ï;»ùÒò¹¤³Ì
ØÁÁ¢·å(1978Äê¡«),ÄÐ,²©Ê¿Ñо¿Éú,¶¯ÎïÓªÑøÓëËÇÁÏ¿ÆÑ§×¨Òµ,Ñо¿·½ÏòΪ¶¯Îï·Ö×ÓÓªÑøÑ§¡£
¡¡¡¡¸ÉÈÅËØ(IFN)ÊǶ๦ÄÜϸ°ûÒò×Ó¼Ò×åÖеÄÒ»
Ô±¡£1957Äê,IsaacsºÍLindenmannÀûÓü¦ÅßÈÞë
ÄòÄÒĤÑо¿Á÷¸Ð¸ÉÈÅÏÖÏóʱ·¢ÏÖÊܲ¡¶¾¸ÐȾµÄϸ
°ûÄܲúÉúÒ»ÖÖÒò×Ó,×÷ÓÃÓÚÆäËüϸ°ûʱÄܸÉÈŸÐȾ
²¡¶¾µÄ¸´ÖÆ,Òò¶ø½«ÆäÃüÃûΪIFN¡£Ä¿Ç°ÒÑÖªIFN
ÊÇÒ»Àà¸ß»îÐԵĶ๦ÄÜÌǵ°°×¡£IFN»ùÒòºËËáÐò
ÁзÖÎö½á¹û±íÃ÷,ËüÓÚ5¡«l0ÒÚÄêǰ¼´´æÔÚÓÚÉúÎï
ϸ°ûÖÐ,ÊÇÉúÎïÌåÄÚÒ»Àà¹ÅÀϵı£»¤Òò×Ó¡£IFNÔÚ
¿¹²¡¶¾ÐÔ¼²²¡ºÍ¶ñÐÔÖ×ÁöÒÔ¼°ÔöÇ¿»úÌåÃâÒßµ÷½Ú
ÄÜÁ¦·½ÃæÓÐÃ÷ÏÔЧ¹û,Æä¿¹²¡¶¾»îÐÔÊÇÓÉϸ°ûÊÜÌå
½éµ¼²¢ÒÀÀµÓÚÐźÅ;¾¶µÄ¼¤»î¡¢ÌØÒì»ùÒò²úÎïµÄ±í
´ï¼°¿¹²¡¶¾»úÖÆµÄÌØÐÔ¡£IFNͨ¹ýÓëϸ°ûĤÉϵÄ
ÌØÒìÐÔÊÜÌå½áºÏ,ÓÕµ¼°Ðϸ°û²úÉúÌØÒìÐÔ¹¦Äܵ°
°×,Èçµ°°×¼¤Ã¸ºÍ2'5'¹Ñ¾ÛÏÙÜÕËáºÏ³Éø,½ø¶ø
Òý·¢¼¶ÁªÐÔµÄÐźŷŴó¹ý³Ì,½«ÐźÅ×îºó´«µÝµ½Ï¸
°ûºËÄÚ,¶ÔһϵÁлùÒòµÄ±í´ï½øÐе÷¿Ø,²¢Òý·¢¸÷
ÖÖÉúÀí·´Ó¦[1]¡£IFNÆäËü»îÐÔ°üÀ¨ÒÖÖÆÏ¸°ûÔöÖ³¡¢
µ÷½Ú¹¦ÄÜÐÔϸ°û»îÐÔ¼°¶Ôϸ°û·Ö»¯ÓëÃâÒߵĵ÷¿Ø¡£
IFNͨ¹ýÔöÇ¿¾ÞÊÉϸ°ûµÄÍÌÊÉ»îÐÔ¼°ÁܰÍϸ°û¶Ô
°Ðϸ°ûµÄÌØÊâϸ°û¶¾ÐÔ,Æðµ½ÃâÒßµ÷½Ú×÷Óá£Ëæ×Å
·Ö×ÓÉúÎïѧ¡¢DNAÖØ×é¼¼ÊõµÄ²»¶Ï·¢Õ¹,ÀûÓûùÒò
¹¤³Ì¼¼ÊõÉú²úÖØ×éIFN,ÒѳÉΪÑо¿µÄÖØÒªÄÚÈÝ¡£
1¡¡IFN·ÖÀàÓë·Ö×ӽṹ
1.1¡¡IFN·ÖÀà¡¡IFNµÄÀ´Ô´Òò¶¯ÎïÖÖÀࡢϸ°ûÀà
ÐÍ¡¢ÓÕÉú¼ÁµÄÐÔÖʺÍÓÕÉúÌõ¼þ¶øÒì,¿É·ÖΪÀ´×Ô°×
ϸ°ûµÄIFN¦Á,À´×ÔÏËάĸϸ°ûµÄIFN¦ÂºÍÀ´×Ô
ÁܰÍϸ°ûµÄIFN¦Ã¡£IFN¦ØÒ²ÊôÓÚ°×ϸ°ûÔ´
IFN,IFN¦ÊÊÇÒ»ÐÂÐ͵ÄÏËάϸ°ûÔ´IFN¡£ÆäÖÐ,
ÄÍËáµÄIFN¦Á¡¢IFN¦Â¡¢IFN¦ØÓëIFN¦ÊÓֺϳÆ
ΪIÐÍIFN;¶ÔËáÃô¸ÐµÄIFN¦Ã³ÆÎª¢òÐÍIFN»ò
ÃâÒßIFN¡£IFN¦Á´æÔÚ¶àÖֽṹÐòÁв»Í¬µÄÑÇ
ÐÍ,·Ö±ðÃüÃûΪ¦Á1¡¢¦Á2¡¢¦Á3µÈ,ĿǰÒѾ­¼ø¶¨µÄIFN
¦ÁÑÇÐÍÖÁÉÙÓÐ23ÖÖÖ®¶à¡£Óɲ¡¶¾¡¢Î¢ÉúÎï¼°Æä²ú
ÎïÓÕµ¼²úÉúµÄIÐÍIFNÖ÷Òª²ÎÓ뿹²¡¶¾¡¢¿¹Ö×Áö
»îÐÔ,ÈçÓÕµ¼ºÏ³É¿¹²¡¶¾µ°°×¡¢2'5'ÏÙÜÕËáºÏ³É
ø;ÓÉÁܰÍϸ°ûÊÜÓÐË¿·ÖÁÑÔ­»òÌØÒ쿹ԭ´Ì¼¤²úÉú
µÄ¢òÐÍIFNÖ÷Òª²ÎÓëÓÕµ¼MHCÀ࿹ԭµÄ±í´ïºÍ
ÃâÒßµ÷½ÚЧӦ,µ«Æä¿¹²¡¶¾×÷ÓñÈIÐÍIFNÈõ¡£
1.2¡¡IFNµÄ·Ö×ӽṹ¡¡IFN¾ßÓйãÆ×ÓÕµ¼¿¹²¡¶¾
»îÐÔ¡£°×ϸ°ûIFN¦ÁµÄ¸÷ÑÇÐ;ùº¬165¡«166¸ö
°±»ùËá²Ð»ù,½á¹¹ÏàËÆ;IFN¦Âº¬166¸ö°±»ùËá²Ð
»ù;IFN¦Øº¬172¡«174¸ö°±»ùËá²Ð»ù¡£²»Í¬ÀàÐÍ
IFN·Ö×Ó¾ßÓв»Í¬³Ì¶ÈµÄ°±»ùËáͬԴÐÔ(IFN¦Á
ÓëIFN¦Â·Ö×ÓͬԴÐÔΪ28%,ÓëIFN¦Ø·Ö×Óͬ
Ô´ÐԸߴï60%)¡£IFN¦ÁÓëIFN¦ÂµÄ½á¹¹»ùÒò
¾ù¶¨Î»ÓÚÈ˵ĵھźÅȾɫÌåÉÏ,¶øÇÒ¶¼²»º¬ÓÐÄÚº¬
×Ó¡£IFN¦Ã»ùÒò¶¨Î»ÓÚµÚ12ºÅȾɫÌåÉÏ,¹²º¬ÓÐ
3¸öÄÚº¬×Ó¡£Ä¿Ç°ÒѼø¶¨³öµÄIFN¦Á·ÇµÈλ»ùÒò
ÖÁÉÙÓÐ15¸ö,¶øIFN¦ÂºÍIFN¦Ã¾ùÓɵ¥»ùÒò±à
Âë¡£¶¯ÎïIFN¦Ã»ùÒò4¸öÍâÏÔ×Ó±àÂëÊýÄ¿Ïà½ü
µÄ°±»ùËá¡£µÚÒ»¸öÍâÏÔ×Ó°üº¬5'UTR¡¢19¸ö°±»ù
ËáµÄÐźÅÐòÁкÍ22¸ö°±»ùËáµÄ³ÉÊìµ°°×ÖÊ¡£ÍâÏÔ
¡¤22¡¤ÖйúÊÞÒ©ÔÓÖ¾¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡2003,37(6):22¡«25/ØÁÁ¢·å,µÈ¡¡
ology in transgenic mice with CNS expression of IFN-¦Á[J].Brain
Research,1999,835(1):46-61.
[2]Anthony Meager.Biological assays for Interferons[J].Journal of
Immunological Methods,2002,261:21-36.
[3]Pete Kaiser,Hester M Wain,Lisa Rothwell.Structure of the
chicken interferon-¦Ãgene,and comparison to mammalian homo-
logues[J].Gene,1998,207:25-32.
[4]Xiao Weihua,Wang Ling.Regulation of interferon-¦Á/¦Â-stimulated
gene expression through the gamma-activated transcriptional
element[J].Antiviral Research,1999,40:145-153.
[5]David ELevy,Adolfo Garcia-Sastre.The virus battles:IFN in-
duction of the antiviral state and mechanisms of viral evasion[J].
Cytokine&Growth Factor Reviews,2001,12:143-156.
[6]Mitsuharu Sato,Naoki Hata.Positive feedback regulation of type
I IFN genesby the IFN-inducible transcription factor IRF-7[J].
FEBS Letters,1998,441:106-110.
[7]Servant MJ,Tenoever B.Overlapping and distinct mechanisms
regulating IRF-3 and IRF-7 function[J].Journal of Interferon and
Cytokine Research,2002,22(1):49-58.
[8]Nguyen,Hannah,Hiscot John.The growing family of interferon
regulatory factors[J].Cytokine&Growth Factor Reviews,
2001,8(2-3):133-142.
[9]Eason Donna,D Shepherd,Alexander T.Interferon regulatory
factor 1 tryptophan 11 to arginine point mutation abolishes DNA
binding[J].Biochimica et Biophysica Acta(BBA)/Gene Structure
and Expression,1999,1446(1-2):140-144.
[10]Manuel Rodriguez,Vladimir Martinez.The bovine IFN-¦Ø1 is
biologically active and secreted at high levels in the yeast Pichia
pastoris[J].Journal of Biotechnology,1998,60:3-14.
The molecular biological research of interferons
QI Li-feng,XU Zi-rong
(Feed Science Institute ofZhejiang University,The Education MinistryKey LaboratoryofAnimal
Molecular Nutrition,Hangzhou,Zhejiang310029;China)
Abstract:Belong to a kind of multifunctional cytokines,interferons are potent biologically active proteins
synthesized and secreted by somatic cells of all mammalian species.Interferons'biological activities include
antiviral activity,inhibition of cell proliferation,regulation of cellular differentiation and immunomodulation.
Gene expression of interferons is regulated by various factors and regulatory elements.Interferons have been
applied to disease diagnoses.And people have paid more attention to interferons'gene engineering and gene
therapy.
Key words:interferons;gene expression;gene engineering
ũҵ²¿ÒßÔ´µ÷²é×é:ÈËÀàSARS²¡¶¾¿ÉÄÜÀ´×ÔÒ°Éú¶¯Îï
ÎÒ¹úSARS²¡¶¾ÆðÔ´Ñо¿¹¤×÷È¡µÃÍ»ÆÆ,ר¼ÒÃÇÒÑ´Óòùò𡢺¹û×ÓÀêÒÔ¼°ÉßµÈÊýÖÖ¶¯ÎïÌåÄÚ¼ì²âµ½¹Ú×´²¡¶¾»ùÒò,ÒÑ
²â³öµÄ²¡¶¾»ùÒòÐòÁÐÓëSARS²¡¶¾µÄ»ùÒòÐòÁÐÍêȫһÖ¡£
¾ÝÁ˽â,ũҵ²¿ºÍ¹ã¶«Ê¡ÁªºÏ×éÖ¯Á˿Ƽ¼¹¥¹ØÐ¡×é,Ôڹ㶫ʡÂÊÏÈ¿ªÕ¹SARS²¡¶¾ÒßÔ´µ÷²é¹¤×÷¡£µ÷²é×éÓÉÖйúũҵ
¿ÆÑ§Ôº¹þ¶û±õÊÞÒ½Ñо¿Ëù¡¢½â·Å¾ü¾üÐè´óѧ¡¢»ªÄÏũҵ´óѧºÍ¹ã¶«Ê¡¶¯Îï·ÀÒ߼ල×ÜËù¡¢¹ã¶«Ê¡¼²²¡Ô¤·À¿ØÖÆÖÐÐĵÈÊÞÒ½¡¢
ÎÀÉúµ¥Î»µÄר¼Ò×é³É¡£Ä¿Ç°ÒѲɼ¯59ÖÖ¶¯Îï¹²¼Æ1700Í·(Ö»)·Ý¶¯ÎïÑùÆ·¡£µ÷²é×éÈÏΪ,SARS²¡¶¾»òÀàSARS¹Ú×´²¡¶¾
¿ÉÄÜ´æÔÚÓÚÈô¸ÉÒ°Éú¶¯ÎïÌåÄÚ¡£²¡¶¾µÄϵͳÏêϸ¼ø¶¨ÒÔ¼°¶¯ÎïÖеÄSARS²¡¶¾»òÀàSARS¹Ú×´²¡¶¾ÊÇÈçºÎÒýÆðÈËÀà·¢²¡
µÈÎÊÌâ,ÕýÔÚ½øÒ»²½Ñо¿ÖС£
ÉîÛÚÓëÏã¸ÛºÏ×÷·¢ÏÖÈËÀàSARS²¡¶¾À´×ÔÒ°Éú¶¯Îï¡£
ÉîÛÚÊм²²¡Ô¤·À¿ØÖÆÖÐÐÄÓëÏã¸Û´óѧ΢ÉúÎïѧϵ¡¢ÉîÛÚ¶¯Îï·ÀÒ߼ලËù¡¢ÉîÛÚÊÐÒ°Éú¶¯Ö²Îï±£»¤Õ¾ÁªºÏ×é³É¹¥¹ØÐ¡
×é¡£¹¥¹ØÐ¡×é´Ó6Ö»¹û×ÓÀê±ê±¾ÖзÖÀëµ½3ÖêSARSÑù²¡¶¾;¶ÔÆäÖÐ1Öê½øÐлùÒòÈ«ÐòÁвⶨ,½á¹ûÏÔʾ:¹û×ÓÀêSARSÑù
²¡¶¾ÓëÈËÀàSARS²¡¶¾ÓÐ99%ÒÔÉϵÄͬԴÐÔ¡£½øÒ»²½µÄ»ùÒò·ÖÎö,Ö¤Ã÷Á˶¯ÎïSARSÑù²¡¶¾ÊÇÈËÀàSARS²¡¶¾µÄǰÌ塣ͬ
ʱ,ÔÚ¶Ô10ÃûÒ°Éú¶¯Îï¾­ÓªÕß½øÐеÄSARS²¡¶¾¿¹Ìå¼ì²â·ÖÎöÖÐ,5È˳ÊÑôÐÔ·´Ó¦,ÌáʾҰÉú¶¯ÎïÌåÄÚ´æÔÚµÄSARSÑù²¡
¶¾¿ÉÄÜÒ²¸ÐȾÃÜÇнӴ¥Õß¡£
ÕâÏîÑо¿³É¹ûΪ½øÒ»²½²ûÃ÷ÈËÀàSARSµÄÔ´Í·¼°´«²¥Á´ÌṩÁËÖØÒªÖ¤¾Ý,ҲΪÏÂÒ»²½ÑÐÖÆSARS²¡¶¾ÒßÃç¡¢·ÀÖÎÒ©Îï
µÈÌṩÁ˼¼ÊõÖ§³Ö¡£
(¡¶ÈËÃñÈÕ±¨¡·2003Äê05ÔÂ24ÈÕµÚ¶þ°æ)
¡¤25¡¤¡¡2003,37(6):22¡«25/ØÁÁ¢·å,µÈ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ÖйúÊÞÒ©ÔÓÖ¾
ÎҸоõ×Ô¼ººÃÃìС£¬±»´ó¼Ò˵µÄÒ»ÎÞÊÇ´¦
4Â¥2015-03-03 11:14:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ dongningdz µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á +10 īīĮ 2026-03-18 11/550 2026-03-20 11:57 by ѧԱ8dgXkO
[¿¼ÑÐ] 271²ÄÁϹ¤³ÌÇóµ÷¼Á +7 .6lL 2026-03-18 7/350 2026-03-20 09:10 by xingguangj
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á +5 1ËïÎò¿Õ 2026-03-17 6/300 2026-03-19 23:46 by zcl123
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +10 ÄÝÄÝninicgb 2026-03-15 14/700 2026-03-19 22:59 by ѧԱ8dgXkO
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Ϊѧ666 2026-03-16 7/350 2026-03-19 14:48 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á 324·Ö +10 llllkkkhh 2026-03-18 12/600 2026-03-19 14:33 by llllkkkhh
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼Á +3 xwt¡£ 2026-03-19 3/150 2026-03-19 11:22 by wãåÑôw
[¿¼ÑÐ] 328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑо­Àú +4 ÉúÎ﹤³Ìµ÷¼Á 2026-03-16 12/600 2026-03-19 11:10 by ÉúÎ﹤³Ìµ÷¼Á
[¿¼ÑÐ] »¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á +15 ´óÃ×·¹£¡ 2026-03-15 18/900 2026-03-18 14:52 by haxia
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +6 ½õÀð0909 2026-03-17 6/300 2026-03-18 13:22 by Iveryant
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼²©] 26É격 +4 °Ë6°Ë68 2026-03-16 4/200 2026-03-17 13:00 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] 278Çóµ÷¼Á +3 Yy7400 2026-03-13 3/150 2026-03-17 08:24 by laoshidan
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶Çóµ÷¼Á +6 Ì«Ïë½ø²½ÁË0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] ÇóÀÏʦÊÕÁôµ÷¼Á +4 jiang½ª66 2026-03-14 5/250 2026-03-15 20:11 by Winj1e
[¿¼ÑÐ] 070305Çóµ÷¼Á +3 mlpqaz03 2026-03-14 4/200 2026-03-15 11:04 by peike
[¿¼ÑÐ] 330Çóµ÷¼Á +3 ?½´¸øµ÷¼Á¹òÁË 2026-03-13 3/150 2026-03-14 10:13 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û